mortality/aging
|
• mice frequently die before reaching maturation
|
growth/size/body
|
• severe
|
hematopoietic system
|
• fewer hematopoeitic progenitor cells (HPCs) are detected and the proportion of proliferating cells is decreased
• the number of HPCs in the spleen is increased, with the number of myeloid and multipotential progenitors most significantly increased, and more cells are in a proliferative state compared to in wild-type mice
• following stimulation with growth factors and chemokine treatment in vivo, HPCs are unresponsive to chemokine-induced myelosuppression
• however, HPCs are sensitive to inhibition by TNF-alpha
however, HPCs are sensitive to inhibition by TNF-alpha
|
|
• nucleated-cellularity is decreased by 45% compared to wild-type mice
• however, hypocellularity is consistent with the overall small size of mice
|
|
• nucleated-cellularity is decreased by 26% compared to wild-type mice
• however, hypocellularity is consistent with the overall small size of mice
|
immune system
|
• nucleated-cellularity is decreased by 26% compared to wild-type mice
• however, hypocellularity is consistent with the overall small size of mice
|
|
• Th2-type inflammation develops spontaneously in the heart and lung
|
|
• chemokine levels are greatly increased compared to those in wild-type mice
|
homeostasis/metabolism
|
• chemokine levels are greatly increased compared to those in wild-type mice
|


Analysis Tools